| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.37 | 0.01 |